Heron Therapeuti (HRTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $59.08M
Last updated: Nov 17, 2026 at 11:06 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 12.9% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 42.4, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about HRTX
GNG News
All HRTX newsNews
HRTX Valuation
Heron Therapeuti (HRTX) trades at 47.0x forward earnings.
- Forward P/E
- 47.0x
- P/B
- 14.0x
HRTX Profitability: Margins, ROIC and FCF
Heron Therapeuti (HRTX) has a gross margin of 71.5%, an operating margin of -5.7% and a net margin of -14.5%. It posts -8.4% ROIC and a -9.7% FCF margin.
- Gross margin
- 71.5%
- Operating margin
- -5.7%
- Net margin
- -14.5%
- ROIC
- -8.4%
- ROE
- -217.8%
- FCF margin
- -9.7%
Heron Therapeuti Competitors
The companies most similar to Heron Therapeuti (HRTX) include Coherus BioSciences, Gain Therapeutics and Werewolf Therapeutics.
Sector: Healthcare
Companies most similar to Heron TherapeutiHRTX Bull Case vs Bear Case
Bear case
- HRTX has a -14.5% net profit margin.
- HRTX beat EPS estimates in 37.5% of its last 8 reported quarters.
- HRTX's quarterly revenue changed -7.8% year over year.
HRTX Earnings: Beat Rate and Next Report
Heron Therapeuti (HRTX) beat the EPS estimate in 3 of the last 8 quarters (37.5%).
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -17.1%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.03
HRTX Earnings Call
The latest HRTX earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptHRTX ETF Holders
GNG tracks 4 ETFs that hold HRTX. The largest weights:
- iShares Russell 2000 ETF (IWM), 0.02% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Health Care Index Fund ETF Shares (VHT), <0.01% of the fund
Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About HRTX
Does HRTX pay dividends?
Heron Therapeuti (HRTX) does not currently pay a regular dividend.
What is HRTX's market cap?
Heron Therapeuti (HRTX) has a market capitalization of $59.08M with a current stock price of $0.28.
HRTX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.